![](/img/cover-not-exists.png)
Cost Distribution Analysis Related to the Use of Tyrisine-Kinase Inhibitors (Tki) and the Combination of Pemetrexed/Cisplatin in the Treatment of Non-Small Cell Lung Cancer (Nsclc) Locally Advanced or Metastatic in Presence of Epidermal Growth Factor Receptor (Egfr) Mutations in a Mexican Institutional Context
Huicochea-Bartelt, JL, Palacios, E, Burbano, X, Valencia, C, Herran, SVolume:
18
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2015.09.248
Date:
November, 2015
File:
PDF, 51 KB
english, 2015